Regen BioPharma Inc

Qualified
CIK: 1589150•Nevada•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2834

$3.2M
Qualified
maximum offering price, as qualified
—
Reported Sold
no 1-K or 1-Z states a sold amount
11
Filings
across 3 offerings

Equity Classes

TypeClassOutstandingCUSIPPublicly Traded
commonCommon Stock108,054,70475886M300OTCID Basic
debtConvertible Notes1,006,171——
debtPromissory Notes191,339——
preferredA10,123,77175886M409OTCID Basic
preferredAA34——
preferredM29,338——
preferredNC15,007——

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedPrice/SecuritySecurities OfferedOutstandingAggregate OfferingIssuer PortionSelling HoldersPrior 12mo QualifiedConcurrent OfferingSupplementsLast SupplementWithdrawn
024-1268422025-11-172026-01-082026-01-12$0.00100,000,000108,054,704$700K$450K$0$250K$012025-12-05—
024-1265412025-08-292025-08-292025-09-05$0.1025,000,00032,554,704$2.5M————12025-09-08—
024-1250542024-09-162025-03-032024-12-10$0.0316,666,66721,554,705$0.03————12025-02-242025-08-12
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist

Part of the Alts plan — $40/mo at launch pricing ($100 list)

External link: SEC Filings